文献速递乳腺癌放疗放疗物理与技术

剂量-LET交互预测质子放疗后包膜挛缩

Dose-Linear Energy Transfer Interactions Predict Capsular Contracture After Proton Postmastectomy Radiation Therapy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2026-08-13

该回顾性病例对照研究纳入145例接受质子PMRT的乳腺癌重建患者,8例发生包膜挛缩并与16例对照匹配。研究发现剂量-LET与剂量平均LET的联合效应与包膜挛缩显著相关,并推导出探索性剂量-LET体积约束值。

要点

  • 质子PMRT后包膜挛缩与假体周围组织的剂量-LET联合效应显著相关。
  • 三个DLVH指标与包膜挛缩独立相关,推导出探索性DLVCs。
  • SVM模型预测包膜挛缩的AUC为0.867,准确率91.7%。

核心结论

  • 质子PMRT后包膜挛缩与假体周围组织剂量-LET和剂量平均LET的联合效应显著相关。
  • 推导的DLVCs为探索性候选剂量学约束,需进一步前瞻性验证。

研究设计与样本

  • 回顾性病例对照研究,2015-2021年连续乳腺癌患者接受乳房切除、IBR和常规分割质子PMRT(50 Gy/25次)。
  • 发生Baker III-IV级包膜挛缩者按1:2最近邻匹配对照,共8例病例与16例对照。
  • 计算假体周围5-mm壳层的剂量-LET体积直方图,采用广义线性混合效应回归和ROC分析。

主要发现

  • 三个DLVH指标与包膜挛缩显著相关(P < .01):V(55.8 Gy[RBE=1.1], 2.2 keV/μm)、V(50.3 Gy[RBE=1.1], 5.4 keV/μm)、V(32.8 Gy[RBE=1.1], 0.9 keV/μm)。
  • 经Benjamini-Hochberg校正4096个DLVH指标后,三个指标仍显著(q_Benjamini-Hochberg = 0.052)。
  • SVM基NTCP模型AUC为0.867,准确率91.7%,敏感性87.5%,特异性93.8%。

关键数值与推荐

  • DLVCs:V(55.8 Gy[RBE=1.1], 2.2 keV/μm) < 0.0017%。
  • DLVCs:V(50.3 Gy[RBE=1.1], 5.4 keV/μm) < 0.0033%。
  • DLVCs:V(32.8 Gy[RBE=1.1], 0.9 keV/μm) > 96.98%。

临床怎么用

  • 质子PMRT计划设计时可参考探索性DLVCs评估假体周围组织剂量-LET分布。
  • DLVCs尚未经前瞻性验证,不能作为正式临床约束使用。

局限性

  • 回顾性设计,样本量小(8例事件),DLVCs为探索性且需前瞻性验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Pencil beam scanning proton therapy enables highly conformal dose distributions and is increasingly used for postmastectomy radiation therapy (PMRT) to reduce cardiopulmonary exposure. However, implant-based reconstruction (IBR) in the setting of PMRT remains susceptible to capsular contracture, and the potential contribution of elevated linear energy transfer (LET) in pencil beam scanning has not been well characterized. This study aimed to investigate the combined effects of dose-LET and dose-averaged LET on capsular contracture after proton PMRT and to derive preliminary, exploratory volume cutoff values of dose-LET volume constraints (DLVCs). METHODS AND MATERIALS: We conducted a retrospective case-control study of patients with consecutive breast cancer who underwent mastectomy followed by IBR and conventionally fractionated proton PMRT (50 Gy in 25 fractions) between 2015 and 2021. Patients who developed Baker grades III to IV capsular contracture were identified and matched 1:2 with controls using nearest-neighbor matching based on clinical and pathologic variables. Dose-LET volume histograms (DLVHs) were calculated for peri-implant tissue (5-mm shell around the implant). Generalized linear mixed-effects regression was used to identify DLVH indices significantly associated with capsular contracture. Redundant indices were removed using Spearman correlation analysis. DLVCs were derived from receiver operating characteristic curve analysis and evaluated using a support vector machine-based normal tissue complication probability model with leave-one-out cross-validation. RESULTS: Among 145 consecutive patients, 8 developed capsular contracture and were matched to 16 controls. Three independent DLVH indices were significantly associated with capsular contracture (P < .01): V (55.8 Gy [relative biological effectiveness {RBE} value = 1.1], 2.2 keV/μm), V (50.3 Gy [RBE value = 1.1], 5.4 keV/μm), and V (32.8 Gy [RBE value = 1.1], 0.9 keV/μm). After Benjamini-Hochberg false discovery rate correction across all 4096 DLVH indices, all 3 remained significant (q_Benjamini-Hochberg = 0.052). The corresponding DLVCs were V (55.8 Gy [RBE value = 1.1], 2.2 keV/μm) < 0.0017%, V (50.3 Gy [RBE value = 1.1], 5.4 keV/μm) < 0.0033%, and V (32.8 Gy [RBE value = 1.1], 0.9 keV/μm) > 96.98%. The support vector machine-based normal tissue complication probability model achieved an area under the receiver operating characteristic curve value of 0.867, with an accuracy of 91.7%, a sensitivity of 87.5%, and a specificity of 93.8%. CONCLUSIONS: Capsular contracture following proton PMRT is significantly associated with the combined effects of dose-LET and dose-averaged LET in peri-implant tissue. The derived DLVCs represent exploratory candidate dosimetric constraints that warrant further investigation and prospective validation in patients with breast cancer undergoing proton PMRT with IBR.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Chen J, Ma Z, Cao M, et al. Dose-Linear Energy Transfer Interactions Predict Capsular Contracture After Proton Postmastectomy Radiation Therapy. Int J Radiat Oncol Biol Phys. 2026. PMID: 42595264. doi:10.1016/j.ijrobp.2026.07.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。